Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The up-regulated p53-serine15 phosphorylation (p53-pS15) in keloids is identified by phosphospecific protein microarray and western blotting
Topical makes the most sense for: Facial skin texture, fine lines, hydration Scalp application for localized hair growth Scar treatment or post-procedure recovery on a specific area Patients who want to fold GHK-Cu into an existing skincare routine Injectable makes the most sense for: Systemic wound healing (especially internal or in areas you can't easily apply cream) Joint and connective tissue support (topical simply can't penetrate deep enough) Broader anti-aging goals beyond the skin surface Patients already running other injectable peptide protocols (CJC-1295/ipamorelin, BPC-157, TB-500) Here's the thing: for joints specifically, there's no argument
These trials, as well as studies aimed at determining the levels of GSH in the plasma of PAC-treated vs -untreated COVID-19 patients should be encouraged
GHK-Cu may be the more relevant option when the goal includes broader skin, scalp, collagen, or tissue support
It plays a key role in: Neutralizing harmful free radicals Detoxifying the liver Supporting lung and respiratory health Enhancing immune function Reducing oxidative stress, which contributes to chronic illness When the body metabolizes acetaminophen, it produces a toxic byproduct called NAPQI
This product provides 250 mg of reduced glutathione per capsule
